Mona Li
Impact in
-
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
- Drug Transport and Resistance Mechanisms
-
- DNA Repair Mechanisms
- Biochemical and Molecular Research
- Redox biology and oxidative stress
Papers in
-
- melanin and skin pigmentation 1
- Oncology 2
- PARP inhibition in cancer therapy 1
- Co-authors
- Yimon Aye (1 shared paper)Marcus J. C. Long (1 shared paper)Robert S. Weiss (1 shared paper)Xiaoli Yu (1 shared paper)Rose Hurren (1 shared paper)Victor Wei Teik Ling (1 shared paper)Roman L. Zastawny (1 shared paper)Bin Yu (1 shared paper)
- Journals
- Oncogene (3 papers)Cell Death and Differentiation (1 paper)Fitoterapia (1 paper)PLoS Genetics (1 paper)Vascular Pharmacology (1 paper)
- Partner nations
- CanadaUnited StatesChina
In The Last Decade
Mona Li
9 papers receiving 473 citations
Peers
Comparison fields: 5 of 66
- Oncology 125
- Molecular Biology 211
- Cancer Research 44
- Inorganic Chemistry 27
- Hepatology 14
Countries citing papers authored by Mona Li
This map shows the geographic impact of Mona Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mona Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mona Li more than expected).
Fields of papers citing papers by Mona Li
This network shows the impact of papers produced by Mona Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mona Li. The network helps show where Mona Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Mona Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 338 | |
| 2 | 2014 | 83 | |
| 3 | 1999 | 19 | |
| 4 | 2011 | 17 | |
| 5 | 1997 | 11 | |
| 6 | 2019 | 7 | |
| 7 | 2025 | 3 | |
| 8 | 2025 | 2 | |
| 9 | 2018 | 1 |
About Mona Li
Mona Li is a scholar working on Cell Biology, Oncology, Molecular Biology, Cardiology and Cardiovascular Medicine and Economics and Econometrics, having authored 9 papers that have together received 481 indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (1 paper), Ubiquitin and proteasome pathways (1 paper), Health Systems, Economic Evaluations, Quality of Life (1 paper), Cell death mechanisms and regulation (1 paper), Genomics and Chromatin Dynamics (1 paper), PARP inhibition in cancer therapy (1 paper), melanin and skin pigmentation (1 paper) and Biochemical and Molecular Research (1 paper). The work is most often cited by research in Oncology (125 citations), Molecular Biology (211 citations), Cancer Research (44 citations), Inorganic Chemistry (27 citations) and Hepatology (14 citations). Mona Li has collaborated with scholars based in Canada, United States and China. Frequent co-authors include Yimon Aye, Marcus J. C. Long, Robert S. Weiss, Xiaoli Yu, Rose Hurren, Victor Wei Teik Ling, Roman L. Zastawny, Bin Yu, W. Brent Derry and Andrea J. Ross. Their work appears in journals such as Oncogene, Cell Death and Differentiation, Fitoterapia, PLoS Genetics and Vascular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.